Marinomed Biotech AG: cashflow_investing

Value{"amount": -128500.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityMarinomed Biotech AG
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900GN3B1EN80XF405:2023-12-31
Retrieved: 2026-08-23T23:30:46.055423+02:00
Raw response sha256: e0b618315881225c9fcabd47e71fbb09…
Cite as: FACTANKER, https://factanker.com/fact/71ff19be-eea5-421a-a345-860bcf84dd48

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies